Who Owns ARTV?

Artiva Biotherapeutics, Inc. — Institutional Ownership & 13F Holdings

$9.03

-1.73 (-16.05%)

Market Cap

$140.2M

Shares Outstanding

24,716,672

Institutional Holders

52

Total Inst. Value

$33.1M

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
15AM Venture Management, LLC$7.1M2,353,304
2VR Adviser, LLC$4.8M1,609,569
3BlackRock, Inc.$3.7M1,245,511
4venBio Partners LLC$3.6M1,198,975
5Capital World Investors$2.6M866,622
6VANGUARD GROUP INC$2.6M858,214
7FRANKLIN RESOURCES INC$1.6M520,327
8GEODE CAPITAL MANAGEMENT, LLC$1.2M410,457
9Samsara BioCapital, LLC$874K291,666
10Woodline Partners LP$849K283,124

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue
venBio Partners LLC-321K$3.6M
Capital World Investors-49K$2.6M
JPMORGAN CHASE & CO-20K$52K
MORGAN STANLEY-9K$81K
VANGUARD GROUP INC-9K$2.6M

Related Stocks

Frequently Asked Questions

How many institutional investors hold ARTV?

As of Q1 2025, 52 institutional investors report holding ARTV (Artiva Biotherapeutics, Inc.) in their 13F filings.

Which hedge fund owns the most ARTV?

The largest institutional holder of ARTV is 5AM Venture Management, LLC with $7.1M in shares.

Are institutions buying or selling ARTV?

This quarter, 3 institutions opened new positions in ARTV and 9 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.